Hypothalamo-pituitary-adrenal axis in acute myocardial infarction treated by percutaneous transluminal coronary angioplasty: Effect of time of presentation

Journal of Endocrinological Investigation

Volumn 26, Issue 5, 2003, Pages 407-413

  Paganelli, F ^a   Frachebois, C ^a   Velut, J G ^a   Boullu, S ^a   Sauze, N ^b   Rosso, J P ^a   Barnay, P ^a   Sbragia, P ^a   Gelisse, R ^a   Grino, M ^b   Levy, S ^a   Oliver, Charles ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b INSERM   (France)

Author keywords

ACTH; Acute myocardial infarction; Circadian rhythm; Cortisol; HPA axis; PTCA

Indexed keywords

ACETYLSALICYLIC ACID; ARGIPRESSIN; ATENOLOL; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FIBRINOLYTIC AGENT; HEPARIN; HORMONE; HYDROCORTISONE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 10744228484     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345195     Document Type: Article

References (35)

1. Ceremuzynski L. Hormonal and metabolic reactions evoked by acute myocardial infarction. Circ. Res. 1981, 48: 767-776.
2. Logan R.W., Murdoch W.R. Blood levels of hydrocortisone, transaminases, and cholesterol after myocardial infarction. Lancet 1966, 2: 521-524.
3. Bailey R.B., Abernethy M.H., Beaven D.W. Adrenocortical response to the stress of an acute myocardial infarction. Lancet 1967, 1: 970-973.
4. Bain R.J.I., Fox J.P., Jagger J., Davies M.K., Littler W.A., Murray R.G. Serum cortisol levels predict infarct size and patient mortality. Int. J. Cardiol. 1992, 37: 145-150.
5. Wiener K. Plasma cortisol, corticosterone and urea in acute myocardial infarction: Clinical and biochemical correlations. Clin. Chim. Acta 1977, 76: 243-250.
6. Klein A.J., Palmer L.A. Plasma cortisol in myocardial infarction: A correlation with shock and survival. Am. J. Cardiol. 1963, 11: 332-337.
7. Hansen B., Beck-Nielsen J., Juul J., Nielsen B.L., Nielsen F.U. Plasma hydrocortisone values in heart disease. Acta Med. Scand. 1969, 186: 411-416.
8. Prakash R., Parmley W.W., Horvat M., Swan H.J.C. Serum cortisol, plasma free acids, and urinary catecholamines as indicators of complications in acute myocardial infarction. Circulation 1972, 155: 736-745.
9. Chopra M.P., Thadani U., Aber C.P., Portal R.W., Parkes J. Plasma cortisol, urinary 17-hydroxycorticoids, and urinary vanilyl mandelic acid after acute myocardial infarction. Br. Heart J. 1972, 34: 992-997.
10. Nitter-Hauge S., Kirkeby K., Alvsaker J.O., Aakwaag A. Plasma 11-hydroxycorticosteroids in acute myocardial infarction. Acta Med. Scand. 1972, 192: 535-538.
11. Donald R.A., Crozier I.G., Foy S.G. et al. Plasma corticotrophin releasing hormone, vasopressin, ACTH and cortisol responses to acute myocardial infarction. Clin. Endocrinol. (Oxf.) 1994, 40: 499-504.
12. Bain R.J.I., Poeppinghaus V.J.I., Jones G.M., Peaston M.J.T. Cortisol level predicts myocardial infarction in patients with ischaemic chest pain. Int. J. Cardiol. 1989, 25: 69-72.
13. Grines C.L. Primary angioplasty. The strategy of choice. N. Engl. J. Med. 1996, 335: 1313-1317.
14. Caraty A., Grino M., Locatelli A., et al. Insulin-induced hypoglycaemia stimulates corticotropin-releasing factor and arginine vasopressin into hypophysial portal blood of conscious unrestrained rams. J. Clin. Invest. 1990, 85: 1716-1721.
15. Robinson I.C.A.F. The development and evaluation of a sensitive and specific radioimmunoassay for oxytocin in unextracted plasma. Immunoassay. 1980, 1: 323-347.
16. Oldroyd K.G., Harvey K., Gray C.E., Beastall G.H., Cobbe S.M. β Endorphin release in patients after spontaneous and provoked acute myocardial ischaemia. Br. Heart. J. 1992, 67: 230-235.
17. Dampney R.A.L. Functional organisation of central pathways regulating the cardiovascular system. Pharmacol. Rev. 1994, 74: 323-364.
18. Kiss JZ. Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus. Brain Res. Bull. 1998, 20: 966-708.
19. Charles C.J., Rogers S.J., Donald R.A., Ikram H., Prickett T., Richards A.M. Hypothalamo-pituitary-adrenal axis response to coronary artery embolization: An ovine model of acute myocardial infarction. J. Endocrinol. 1997, 152: 489-493.
20. Naito Y., Kukata J., Tamai S., et al. Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery. J. Clin. Endocrinol. Metab. 1991, 73: 111-117.
21. Roth-Isigkeit A., Schmucker P. Postoperative dissociation of blood levels of cortisol and adrenocorticotropin after coronary artery bypass grafting surgery. Steroids 1997, 62: 695-699.
22. Vermes I., Beishuizen A., Hampsink R.M., Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: Possible role of endothelin and atrial natriuretic hormone. J. Clin. Endocrinol. Metab. 1995, 80: 1238-1242.
23. Charlton B.G. Adrenal cortical innervation and glucocorticoid secretion. J. Endocrinol. 1990, 126: 5-8.
24. Marx C., Ehrhart-Bornstein M., Scherbaum W.A., Bornstein S.R. Regulation of adrenocortical function by cytokines - Relevance for immune-endocrine interaction. Horm. Metab. Res. 1998, 30: 416-420.
25. Guillen I., Blanes M., Gomez-Lechon M.J., Castell J.V. Cytokine signaling during myocardial infarction: Sequential appearance of IL-1β and IL-6. Am. J. Physiol. 1995, 269: R229-R235.
26. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front. Neuroendocrinol. 1993, 14: 76-122.
27. Zing H.H. Vasopressin and oxytocin receptors. Baillere's Clin. Endocrinol. Metab. 1996, 10: 75-96.
28. Hader O., Bahr V., Hensen J., Hofbauer K.G., Oelkers WKH. Effects of a V1- vasopressin antagonist on ACTH release following vasopressin infusion or insulin-induced hypoglycemia in normal men. Acta. Endocrinol. (Copenh.) 1990, 123: 622-628.
29. Col J., Petein M., Van Eyll C., Cheron P., Charlier A.A., Pouleur H. Early changes in sodium and water balances in patients with acute myocardial infarction: Relationship to haemodynamics and creatine kinase. Eur. J. Clin. Invest. 1984, 14: 247-254
30. Brar R.B., Stephanou A., Okosi A., Knight R., Lowry P.J., Latchman D.S. Regulation of the CRH promoter in ischaemic cardiac myocytes. Annual Meeting of the Endocrine Society 1998, 207 (Abst.)
31. Muller J.E., Stone P.H., Turi Z.G., et al. Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 1985, 313: 1315-1322.
32. Willich S.N., Linderer T., Wegscheider K., et al. Increased morning incidence of myocardial infarction in the ISAM study: Absence with prior β-adrenergic blockade. Circulation. 1989, 80: 853-858.
33. Boden G. Hormonal and metabolic disturbances during acute and subacute myocardial infarction in man. Diabetologia 1971, 2: 240-246.
34. Oswald G.A., Smith C.C.T., Betteridge D.J., Yudkin J.S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br. Med. J. 1986, 293: 917-922.
35. 2: A preliminary report. J. Lab. Clin. Med. 1996, 128: 115-121.